Abstracts Archive - Page 1605 of 2607 - ACR Meeting Abstracts

Abstract Number: 79 • 2016 ACR/ARHP Annual Meeting
A NOVEL Missense Mvk mutation in a Family with Familial Mediterranean Fever-like Disease
Ilker Karacan¹, Serdal Ugurlu², Aslihan Tolun³, Eda Tahir Turanli¹ and Huri Ozdogan², ¹Department of Molecular Biology and Genetics, İstanbul Technical University, Istanbul, Turkey, ²Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ³Department of Molecular Biology and Genetics, Boğaziçi University, Istanbu, Turkey
Background/Purpose: Monogenic autoinflammatory diseases are mainly disorders of innate immunity and characterized by unprovoked inflammatory attacks. We studied a consanguineous family with two affected children,…
Abstract Number: 80 • 2016 ACR/ARHP Annual Meeting
Impact of a Patient Support Program on Abandonment of Adalimumab Treatment Initiation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis
Philip Mease¹, Manish Mittal², Martha Skup², Matthew Davis³, Arijit Ganguli², Scott Johnson³ and Michael Schiff⁴, ¹Swedish Medical Center and University of Washington, Seattle, WA, ²AbbVie Inc., North Chicago, IL, ³Medicus Economics, LLC, Milton, MA, ⁴University of Colorado, Greenwood Village, CO
Background/Purpose: Treatment abandonment (failure to start therapy after prescription) is common among patients (pts) prescribed specialty pharmaceuticals. AbbVie offers a pt support program (PSP) for…
Abstract Number: 81 • 2016 ACR/ARHP Annual Meeting
Understanding the Importance of a Patient’s Role in the Management of RA: Physician- and Patient-Based Survey
Ara Dikranian¹, James Galloway², Joern Kekow³, Cristiano A.F Zerbini⁴, Maria de la Vega⁵, Gavin Lee⁶, Anna Maniccia⁷, Eustratios Bananis⁸, Dario Ponce de Leon⁹ and Allan Gibofsky¹⁰, ¹San Diego Arthritis Medical Clinic, San Diego, CA, ²King's College, and King´s College Hospital, London, United Kingdom, ³University of Magdeburg, Clinic of Rheumatology, Magdeburg, Germany, ⁴Centro Paulista de Investigação Clinica, São Paulo, Brazil, ⁵CEIM Investigaciones Médicas, Buenos Aires, Argentina, ⁶Hong Kong Sanatorium & Hospital, Hong Kong SAR, China, ⁷Pfizer Inc, New York, NY, ⁸Pfizer Inc, Collegeville, PA, ⁹Pfizer Inc, Lima, Peru, ¹⁰Rheumatology, Weill Cornell Medicine, and Hospital for Special Surgery, New York, NY
Background/Purpose: RA is a chronic, debilitating condition for which there is no cure. To identify and better understand the perspectives of both healthcare providers (HCPs)…
Abstract Number: 82 • 2016 ACR/ARHP Annual Meeting
Patients with Rheumatoid Arthritis in Germany: Are They Ready for Ehealth Via Mobile Medical Applications?
Jutta G. Richter¹, Christina Kampling², Gamal Chehab³, Hasan Acar², Arnd Becker⁴ and Matthias Schneider⁵, ¹Policlinic of Rheumatology and Hiller Research Unit Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, ²Policlinic of Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, ³Policlinic of Rheumatology, Heinrich-Heine-University, 40225 Duesseldorf, Germany, ⁴Ortenau Klinikum Offenburg-Gengenbach, Gengenbach, Gengenbach, Germany, ⁵Department of Rheumatology & Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany
Background/Purpose: Mobile medical Applications (mApps) with diary functions and integrated patient-reported outcome instruments allow patients (pts) with rheumatoid arthritis (RA) to self-monitor their disease apart…
Abstract Number: 83 • 2016 ACR/ARHP Annual Meeting
A Qualitative Study Exploring Participants’ Perception of the Making It Work Program, an Online Program to Help People with Inflammatory Arthritis Maintain Employment
Xi yuan Li^1,2, Pam Rogers¹, Catherine L. Backman^1,3, Charles H. Goldsmith^4,5, Monique Gignac^6,7, Linda Li^1,8, John Esdaile^1,9 and Diane Lacaille^1,9, ¹Rheumatology, Arthritis Research Canada, Richmond, BC, Canada, ²Department of Cellular & Physiological Sciences, The University of British Columbia, Vancouver, BC, Canada, ³Department of Occupational Science & Occupational Therapy, The University of British Columbia, Vancouver, BC, Canada, ⁴Health Sciences, Simon Fraser University, Burnaby, BC, Canada, ⁵The University of British Columbia, Vancouver, BC, Canada, ⁶Institute of Work and Health, Toronto, ON, Canada, ⁷University of Toronto, Toronto, ON, Canada, ⁸Department of Physical Therapy, The University of British Columbia, Vancouver, BC, Canada, ⁹Department of Medicine, Division of Rheumatology, The University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Health services addressing employment needs for people with arthritis are lacking. To address this need, we developed the Making it Work (MiW) program, an…
Abstract Number: 84 • 2016 ACR/ARHP Annual Meeting
Treatment Outcomes and Predictors of Patient Support Program Use Among Patients with Rheumatoid Arthritis: Results from a Post-Marketing Observational Study (PMOS)
Filip van Den Bosch¹, Siegfried Wassenberg², Andrew Östör³, Chen Wang⁴, Jasmina Kalabic⁵ and Vishvas Garg⁴, ¹Rheumatology, Ghent University Hospital, Gent, Belgium, ²Rheumazentrum, Ratingen, Germany, ³Addenbrooke's Hospital, Cambridge, United Kingdom, ⁴AbbVie Inc, North Chicago, IL, ⁵AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
Background/Purpose: Patient (pt) support programs (PSPs) are offered to Rheumatoid arthritis (RA) pts to help manage treatment of this chronic disease. Little information is available…
Abstract Number: 85 • 2016 ACR/ARHP Annual Meeting
Evaluation of Patient Satisfaction with the on-Tracc Program; Benefits of a Joint Approach
Janet Roberts¹, Stephanie O. Keeling² and Steven J. Katz³, ¹Medicine, University of Alberta, Edmonton, AB, Canada, ²University of Alberta, Edmonton, AB, Canada, ³Rheumatology, University of Alberta, Edmonton, AB, Canada
Background/Purpose: The University of Alberta Division of Rheumatology has launched a new multidisciplinary clinic, the On-TRACC Program (On Treating Rheumatoid Arthritis – Providing Access to…
Abstract Number: 86 • 2016 ACR/ARHP Annual Meeting
Optimizing the Efficiency of Patient Data Capture Using Smartphone Technology: Evaluation of the Correlation Between Promis Instruments for PRO Data Capture
Huifeng Yun¹, Jennifer Beaumont², Shuo Yang³, James Willig⁴, W. Ben Nowell⁵, Seth D. Ginsberg⁶, Kelly V. Clayton⁷, Shantana Hazel^7,8, Carole Wiedmeyer⁵ and Jeffrey Curtis⁹, ¹Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, ²Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, ³Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁴Med - Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, ⁵CreakyJoints/Global Health Living Foundation, Upper Nyack, NY, ⁶Global Healthy Living Foundation, CreakyJoints, Upper Nyack, NY, ⁷Global Healthy Living Foundation, Upper Nyack, NY, ⁸Sister Girl Foundation, Inc., Upper Nyack, NY, ⁹Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Patient-reported outcomes (PROs) are key to enabling the comprehensive assessment of patient-centered benefits in comparative effectiveness research (CER). However, the relationships between different PROMIS…
Abstract Number: 87 • 2016 ACR/ARHP Annual Meeting
Familiarity Vital for Telemedicine Uptake Among Parents of Pediatric Rheumatology Patients
Danielle R. Bullock¹, Richard K. Vehe², Lei Zhang³ and Colleen K. Correll¹, ¹Pediatrics, University of Minnesota, Minneapolis, MN, ²Department of Pediatrics, University of Minnesota, Minneapolis, MN, ³University of Minnesota, Minneapolis, MN
Background/Purpose: The United States pediatric rheumatology (PR) workforce is committed to a mission of providing children access to PR care. With a limited number and…
Abstract Number: 88 • 2016 ACR/ARHP Annual Meeting
Patient-Clinician Co-Participation in Design of an App for RA Management Via Telehealth Yields an App with High Usability and Acceptance
Rebecca Grainger^1,2, Tobias Langlotz³, Hermaleigh Townsley⁴ and William Taylor^1,5, ¹University of Otago Wellington, Wellington, New Zealand, ²Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Lower Hutt, New Zealand, ³Department of Information Science, University of Otago, Dunedin, New Zealand, ⁴Department of Medicine, University of Otago Wellington, Wellington, New Zealand, ⁵Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Wellington, New Zealand
Background/Purpose: Traditional management of rheumatoid arthritis (RA) is by rheumatologist review 3 to 6 monthly. This is not sustainable in many healthcare systems as demand…
Abstract Number: 89 • 2016 ACR/ARHP Annual Meeting
2015 ACR/ARHP Workforce Study (WFS): Adult Rheumatology Specialists in the United States: Effect of Gender and Generation
Chad Deal¹, Marcy B. Bolster², Jonathan S. Hausmann³, Daniel Battafarano⁴, Seetha Monrad⁵ and Marcia Ditmyer⁶, ¹Orthopedic and Rheumatology Institute, Cleveland Clinic Foundation, Cleaveland, OH, ²Massachusetts General Hospital, Boston, MA, ³Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, ⁴Medicine, San Antonio Military Medical Center, San Antonio, TX, ⁵Internal Medicine/Rheumatology, University of Michigan, Ann Arbor, MI, ⁶University of Nevada, Las Vegas, NV
Background/Purpose: Workforce surveys are essential to plan for training, recruitment, practice management, funding, and access to care. Gender and generational differences may have significant effects…
Abstract Number: 90 • 2016 ACR/ARHP Annual Meeting
Impacts of Anti-TNF Treatment on Improvement in Work Place and Household Productivity in Patients with Psoriatic Arthritis
Omer Karadag¹, Ediz Dalkilic², Ahmet Mesut Onat³, Orhan Kucuksahin⁴, Timucin Kasifoglu⁵, Bunyamin Kisacik⁶, Omer Nuri Pamuk⁷, Neslihan Yilmaz⁸, Suleyman Serdar Koca⁹, Veli Yazisiz¹⁰, Pinar Talu Ocakci¹¹, Mehmet Sayarlioglu¹², Ender Terzioglu¹³, Sukran Erten^14,15, Mustafa Ferhat Oksuz¹⁶ and Umut Kalyoncu¹, ¹Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ²Department of Rhematology, Uludag University Faculty of Medicine, Bursa, Turkey, ³Department Of Internal Medicine, Division of Rheumatology, Gaziantep University, Gaziantep University,Division of Rheumatology, Gaziantep, Turkey, ⁴Rheumatology, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey, ⁵Rheumatology, Eskisehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey, ⁶Rheumatology Department, Gaziantep University School of Medicine, Gaziantep, Turkey, ⁷Rheumatology, Trakya University Faculty of Medicine, Edirne, Turkey, ⁸Department of Rheumatology, Bilim University Faculty of Medicine, Istanbul, Turkey, ⁹Department of Rheumatology Faculty of Medicine Firat University, Elazig, Turkey, ¹⁰Rheumatology, Akdeniz University Faculty of Medicine, Antalya, Turkey, ¹¹Rheumatology, İzmir University Faculty of Medicine, izmir, Turkey, ¹²Rheumatology, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey, ¹³Division of Rheumatology, Akdeniz University Faculty of Medicine, Antalya, Turkey, ¹⁴Rheumatology, Ataturk Training and Research Hospital, Ankara, Turkey, ¹⁵Rheumatology, Yildirim Beyazit University Faculty Of Medicine, Ankara, Turkey, ¹⁶Rheumatology, Uludag University Faculty of Medicine, Bursa, Turkey
Background/Purpose: Psoriatic arthritis (PsA) is a unique inflammatory arthritis that affects the skin, nails, and the joints. Most of the patients consider PsA to have…
Abstract Number: 91 • 2016 ACR/ARHP Annual Meeting
A Systematic Review of Smartphone Applications for Measuring and Recording Rheumatoid Arthritis Disease Activity
Rebecca Grainger^1,2, Hermaleigh Townsley³, Bonnie White⁴, Tobias Langlotz⁵ and William Taylor^1,6, ¹University of Otago Wellington, Wellington, New Zealand, ²Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Lower Hutt, New Zealand, ³Department of Medicine, University of Otago Wellington, Wellington, New Zealand, ⁴Department of Medicine, University of Otago Wellington, Wellington South, New Zealand, ⁵Department of Information Science, University of Otago, Dunedin, New Zealand, ⁶Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Wellington, New Zealand
Background/Purpose: It is recommended that management of rheumatoid arthritis (RA) requires regular quantitative assessment of RA activity. Treat to target management could be facilitated by use…
Abstract Number: 92 • 2016 ACR/ARHP Annual Meeting
Is Patient Support Program (PSP) Participation Associated with Longer Persistence and Greater Adherence Among New Users of Adalimumab?
Einav Srulovici^1,2, Vishvas Garg³, Adi Ghilai², Becca Feldman², Moshe Hoshen², Ran Balicer², Martha Skup⁴ and Maya Leventer-Roberts², ¹School of Nursing, University of Haifa, Haifa, Israel, ²Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel, ³AbbVie Inc, North Chicago, IL, ⁴AbbVie Inc., North Chicago, IL
Background/Purpose: In Israel, patients treated with adalimumab (ADA) can enroll in a patient support program (PSP) provided by AbbVie, which includes a home visit by…
Abstract Number: 93 • 2016 ACR/ARHP Annual Meeting
2015 ACR/ARHP Workforce Study in the United States: Adult Rheumatologist Supply and Demand Projections for 2015-2030
Daniel Battafarano¹, Seetha Monrad², John Fitzgerald³, Marcy Bolster⁴, Chad Deal^5,6, Anne R. Bass⁷, Rodolfo Molina⁸, Alan R. Erickson⁹, Benjamin J Smith¹⁰, Karla B. Jones¹¹, Jonathan S. Hausmann¹², Val Gokenbach¹³, Kamilah Lewis¹⁴ and Marcia Ditmyer¹⁵, ¹Medicine, San Antonio Military Medical Center, San Antonio, TX, ²Internal Medicine/Rheumatology, University of Michigan, Ann Arbor, MI, ³Medicine, UCLA, Los Angeles, CT, ⁴Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, ⁵Orthopedic and Rheumatology Institute, Cleveland Clinic Foundation, Cleaveland, OH, ⁶Dept of Rheum & Imm Dis /A 50, Cleveland Clinic Foundation, Cleveland, OH, ⁷Rheumatology, Hospital for Special Surgery, New York, NY, ⁸Arthritis Associates PA, San Antonio, TX, ⁹Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, ¹⁰Rheumatology, McIntosh Clinic, P.C., Thomasville, GA, ¹¹Rheumatology, Nationwide Children's, Columbus, OH, ¹²Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, ¹³Academy for Academic Leadership, Detroit, MI, ¹⁴American College of Rheumatology, Atlanta, GA, ¹⁵Academy for Academic Research, Las Vegas, NV
Background/Purpose: The 2015 ACR Workforce study updated the current and projected adult rheumatology workforce for the next 15 years. Methods: The 2015 ACR/ARHP Workforce…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].